Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting.

Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Abstract Text:

Frederick A Spencer,Darleen Lessard,Chyke Doubeni,Jorge Yarzebski,Joel M Gore,Robert J Goldberg,

BACKGROUND: There are little contemporary data available describing the hospital and long-term outcomes of patients with peripheral arterial disease (PAD) who are hospitalized with acute myocardial infarction (AMI). The objectives of our population-based study were to examine the hospital and long-term outcomes, as well as the use of different treatment practices, among patients with established PAD who were hospitalized with AMI. METHODS: The study sample consisted of 4480 patients hospitalized with AMI at all Worcester, Mass, medical centers in 4 alternate years between 1997 and 2003. RESULTS: Among the metropolitan Worcester residents hospitalized with AMI, 13.5% had a history of PAD. Prior use of proven cardiac therapies in patients with, and without, PAD was less than optimal though more often used in patients with prior PAD. Patients with PAD were significantly less likely to be treated with thrombolytic therapy during hospitalization than patients without PAD. Patients with PAD were not at significantly increased risk of dying during hospitalization (adjusted OR 1.29, 0.95% CI 0.97-1.71), though they were at a significantly increased risk of dying at 1 year after hospital discharge (adjusted OR 2.00, 95% CI 1.58-2.52) in comparison with patients without prior PAD. CONCLUSIONS: Approximately 1 in 8 patients presenting with AMI in this community-wide study had a history of clinically recognized PAD. These patients are at increased risk of dying during the first year after hospital discharge. Our data indicate that there is a room for improvement for the enhanced use of effective treatment modalities and implementation of secondary prevention strategies in these high-risk patients.

Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Publishing Authors By Initials

FA Spencer,D Lessard,C Doubeni,J Yarzebski,JM Gore,RJ Goldberg,

For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

PUBMED ID PMID:

MEDLINE DATE:

Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: American heart journal

VOLUME: 153

Page Numbers: 140-6

Journal Abbreviation: Am. Heart J.

ISSN: 1097-6744

DAY: 3

MONTH: Jan

YEAR: 2007

Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370465

Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Keywords Mesh Terms:

KEYWORDS: Treatment Outcome

MESH TERMS: utilization

Chemical & Substance for Abstract: Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Information

Substance Name: Aspirin

Registry Number: 50-78-2

Grant and Affiliation Information for Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting.

AFFILIATION: Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Country: United States

AGENCY: United States NHLBI

GRANT: R01 HL35434

ACRONYM: HL

MEDLINETA: Am Heart J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting Related Publications

• A combinatorial approach to minimal peptide models of a metalloprotein active site.
• A first large cohort study of personality trait stability over the 40 years between elementary school and midlife.
• A low-spin alkylperoxo-iron(III) complex with weak Fe-O and O-O bonds: implications for the mechanism of superoxide reductase.
• A role for falcilysin in transit peptide degradation in the Plasmodium falciparum apicoplast.
• Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors.
• Cytogenetic Effects of Antibodies to gamma-Interferon in Ultralow Doses.
• Diversity and evolution of West Nile virus in Illinois and the United States, 2002-2005.
• Effect of ultralow doses of antibodies to erythropoietin on antenatal and postnatal development of the offspring.
• Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle.
• Envisioning outcomes from choosing the midwifery model of perinatal care.
• Erythropoietic activity of preparations containing receptors and antibodies to erythropoietin in ultralow doses.
• Hemoglobin-degrading plasmepsin II is active as a monomer.
• Immunotropic Effects of Potentiated Antibodies to Human Interferon-gamma.
• Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population.
• Laser removal of pigmented and vascular lesions.
• Legal considerations in cosmetic laser surgery.
• Molecular probes of DNA bulges: functional assay and spectroscopic analysis.
• Nuchal translucency screening: how do women actually utilize the results?
• Optimization of HDR brachytherapy dose distributions using linear programming with penalty costs.
• Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
• Probing DNA bulges with designed helical spirocyclic molecules.
• Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases.
• Reaction times of manual responses to a visual stimulus at the goal of a planned memory-guided saccade in the monkey.
• Role of peripherin/rds in vertebrate photoreceptor architecture and inherited retinal degenerations.
• Thermodynamics of carbohydrate isomerization reactions The conversion of aqueous allose to psicose.
• Thermodynamics of the conversion of aqueous xylose to xylulose.
• Timing of Diosgenin Appearance in Suspension Cultures of Dioscorea deltoidea.
• Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting.
• Twin study of depressive symptoms among older african-american women.
• Use of do-not-resuscitate orders in patients with kidney disease hospitalized with acute myocardial infarction.